Alpha 2.0
Login Register
» Authors » Asbjorn Hrobjartsson

Asbjorn Hrobjartsson

Explore the profile of Asbjorn Hrobjartsson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 143
Citations 58479
Followers 0
Related Specialties
General Medicine
Public Health
Health Services
Top 10 Co-Authors
Isabelle Boutron
Peter C Gotzsche
An-Wen Chan
David Moher
Andreas Lundh
Stig Brorson
Douglas G Altman
Lesley A Stewart
Philippe Ravaud
Matthew J Page
Published In
J Clin Epidemiol
BMJ
Cochrane Database Syst Rev
Ugeskr Laeger
Syst Rev
Affiliations
Soon will be listed here.
Recent Articles
1.
Scoping review of registration of observational studies finds inadequate registration policies, increased registration, and a debate converging toward proregistration
Malmsio D, Norlen S, Jespersen C, Neesgaard V, Song Z, Chan A, et al.
J Clin Epidemiol . 2025 Jan; 180:111686. PMID: 39862933
Objectives: We aimed to examine a) the policies of national and international clinical trial registries regarding observational studies; b) the time trends of observational study registration; and c) the published...
2.
Peer reviewers' conflicts of interest in biomedical research: scoping review
Korfitsen C, Hansen Nejstgaard C, Hrobjartsson A, Boutron I, Bero L, Lundh A
BMJ Evid Based Med . 2025 Jan; PMID: 39788692
Background: Peer review may improve the quality of research manuscripts and aid in editorial decisions, but reviewers can have conflicts of interest that impact on their recommendations. Objectives: The objective...
3.
Integrating environmental outcomes in randomised clinical trials: a call to action
Petersen J, Hemberg L, Thabane L, Hopewell S, Chan A, Hrobjartsson A, et al.
Lancet . 2024 Dec; 405(10477):446-448. PMID: 39718177
No abstract available.
4.
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration
Manyara A, Davies P, Stewart D, Weir C, Young A, Blazeby J, et al.
BMJ . 2024 Jul; 386:e078524. PMID: 38981645
No abstract available.
5.
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration
Manyara A, Davies P, Stewart D, Weir C, Young A, Blazeby J, et al.
BMJ . 2024 Jul; 386:e078525. PMID: 38981624
No abstract available.
6.
Lundh A, Hrobjartsson A
Ugeskr Laeger . 2024 Jun; 186(24). PMID: 38903039
No abstract available.
7.
A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E)
Higgins J, Morgan R, Rooney A, Taylor K, Thayer K, Silva R, et al.
Environ Int . 2024 Mar; 186:108602. PMID: 38555664
Background: Observational epidemiologic studies provide critical data for the evaluation of the potential effects of environmental, occupational and behavioural exposures on human health. Systematic reviews of these studies play a...
8.
Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements
Tunn R, Boutron I, Chan A, Collins G, Hrobjartsson A, Moher D, et al.
J Clin Epidemiol . 2024 Mar; 169:111309. PMID: 38428538
Objectives: To describe, and explain the rationale for, the methods used and decisions made during development of the updated SPIRIT 2024 and CONSORT 2024 reporting guidelines. Methods: We developed SPIRIT...
9.
Transitivity, coherence, and reliability of network meta-analyses comparing proximal humerus fracture treatments: a meta-epidemiological study
Sandau N, Aagaard T, Hrobjartsson A, Harris I, Brorson S
BMC Musculoskelet Disord . 2024 Jan; 25(1):14. PMID: 38166880
Background: Network meta-analyses can be valuable for decision-makers in guiding clinical practice. However, for network meta-analysis results to be reliable, the assumptions of both transitivity and coherence must be met,...
10.
Granholm A, Moller M, Gluud C, Lundh A, Hrobjartsson A, de Muckadell O, et al.
Ugeskr Laeger . 2023 Nov; 185(45). PMID: 37987450
The randomised clinical trial is the most reliable study design to compare the effects of different interventions, however, the methodological quality of randomised clinical trials varies. In this review, the...